Viewing Study NCT06916767


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-25 @ 5:50 PM
Study NCT ID: NCT06916767
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2025-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Sponsor: Paolo Caimi, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module